AAAAAA

   
Results: 1-12 |
Results: 12

Authors: Cuello, M Ettenberg, SA Nau, MM Lipkowitz, S
Citation: M. Cuello et al., Synergistic induction of apoptosis by the combination of TRAIL and chemotherapy in chemoresistant ovarian cancer cells, GYNECOL ONC, 81(3), 2001, pp. 380-390

Authors: Ettenberg, SA Magnifico, A Cuello, M Nau, MM Rubinstein, YR Yarden, Y Weissman, AM Lipkowitz, S
Citation: Sa. Ettenberg et al., Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complex, J BIOL CHEM, 276(29), 2001, pp. 27677-27684

Authors: Cuello, M Ettenberg, SA Clark, AS Keane, MM Posner, RH Nau, MM Dennis, PA Lipkowitz, S
Citation: M. Cuello et al., Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhancestumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosisin breast and ovarian cancer cell lines that overexpress erbB-2, CANCER RES, 61(12), 2001, pp. 4892-4900

Authors: Borinstein, SC Hyatt, MA Sykes, VW Straub, RE Lipkowitz, S Boulter, J Bogler, O
Citation: Sc. Borinstein et al., SETA is a multifunctional adapter protein with three SH3 domains that binds Grb2, Cbl, and the novel SB1 proteins, CELL SIGNAL, 12(11-12), 2000, pp. 769-779

Authors: Lin, Y Devin, A Cook, A Keane, MM Kelliher, M Lipkowitz, S Liu, ZG
Citation: Y. Lin et al., The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of I kappa B kinase and c-Jun N-terminal kinase, MOL CELL B, 20(18), 2000, pp. 6638-6645

Authors: Keane, MM Rubinstein, Y Cuello, M Ettenberg, SA Banerjee, P Nau, MM Lipkowitz, S
Citation: Mm. Keane et al., Inhibition of NF-kappa B activity enhances TRAIL mediated apoptosis in breast cancer cell lines, BREAST CANC, 64(2), 2000, pp. 211-219

Authors: Bachmaier, K Krawczyk, C Kozieradzki, I Kong, YY Sasaki, T Oliveira-dos-Santos, A Mariathasan, S Bouchard, D Wakeham, A Itie, A Le, J Ohashi, PS Sarosi, I Nishina, H Lipkowitz, S Penninger, JM
Citation: K. Bachmaier et al., Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b, NATURE, 403(6766), 2000, pp. 211-216

Authors: Levkowitz, G Waterman, H Ettenberg, SA Katz, M Tsygankov, AY Alroy, I Lavi, S Iwai, K Reiss, Y Ciechanover, A Lipkowitz, S Yarden, Y
Citation: G. Levkowitz et al., Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1, MOL CELL, 4(6), 1999, pp. 1029-1040

Authors: Elly, C Witte, S Zhang, ZH Rosnet, O Lipkowitz, S Altman, A Liu, YC
Citation: C. Elly et al., Tyrosine phosphorylation and complex formation of Cbl-b upon T cell receptor stimulation, ONCOGENE, 18(5), 1999, pp. 1147-1156

Authors: Keane, MM Ettenberg, SA Nau, MM Banerjee, P Cuello, M Penninger, J Lipkowitz, S
Citation: Mm. Keane et al., cbl-3: a new mammalian cbl family protein, ONCOGENE, 18(22), 1999, pp. 3365-3375

Authors: Ettenberg, SA Keane, MM Nau, MM Frankel, M Wang, LM Pierce, JH Lipkowitz, S
Citation: Sa. Ettenberg et al., cbl-b inhibits epidermal growth factor receptor signaling, ONCOGENE, 18(10), 1999, pp. 1855-1866

Authors: Keane, MM Ettenberg, SA Nau, MM Russell, EK Lipkowitz, S
Citation: Mm. Keane et al., Chemotherapy augments TRAIL-induced apoptosis in breast cell lines, CANCER RES, 59(3), 1999, pp. 734-741
Risultati: 1-12 |